Risk Reduction: Clinical Trials

4 trials for Risk Reduction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Active not recruiting 1
Phase 11Completed 1

Follow Risk Reduction: new trials by email Literature Review of Risk Reduction trials Research Report on Risk Reduction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Bazedoxifene and Conjugated Estrogens - Risk Reduction, Breast Cancer
Phase 2Active not recruitingUniversity of Kansas Medical Center1202021-12-142026-10-27
Low Dose Tamoxifen for Mammographic Density Reduction
Tamoxifen Oral Tablet, Placebo Oral Tablet - Risk Reduction, Mammographic Density Reduction
Phase 2CompletedPer Hall14402016-11-012025-03-07
BEing Safe in Treatment
BEST assessment only, BEST assessment plus feedback report, Standard Counselor Training - Risk Behavior, Sex, Unsafe
Phase 2CompletedUniversity of Washington5372015-06-012018-07-02
Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)
PROJECT POWER, Power Health - Unsafe Sex, Risk Reduction
Phase 1 / Phase 2CompletedNova Southeastern University2112011-07-012014-03-11

Narrower conditions

Risk Reduction Behavior (4)  ·  Breast Neoplasms (2)  ·  Unsafe Sex (2)  ·  Hot Flashes (1)  ·  Risk-Taking (1)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (4)  ·  Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Sexual Behavior (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Advance Directives (1)  ·  Estrogens, Conjugated (USP) (1)  ·  Tamoxifen (1)  ·  bazedoxifene (1)

Sponsors

Nova Southeastern University (1)  ·  Per Hall (1)  ·  University of Kansas Medical Center (1)  ·  University of Washington (1)

Countries

United States (2)

Top investigators

Carol J Fabian, MD (1)  ·  Per Hall, Professor (1)

Results publications

PMID 33734864, PMID 35751944, PMID 36637153, PMID 37149701, PMID 38554131, PMID 39293780, PMID 39593191, PMID 42720596

NIH funding

2016 (1), R01CA249437 (1), R01HD078163 (1)